Sichuan Goldstone Asia Pharmaceutical Inc. (SHE:300434)
China · Delayed Price · Currency is CNY 13.16
+0.75 (6.04%)
Oct 9, 2026, 1:35 PM CST
SHE:300434 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 1,037 | 1,038 | 1,102 | 1,209 | 1,243 | 1,054 |
Revenue Growth | -3.24% | -5.80% | -8.84% | -2.69% | 17.95% | 35.53% |
Gross Profit Gross Profit Growth | 619.65 | 603.02 | 629.17 | 741.21 | 761.87 | 593.94 |
Operating Income Operating Income Growth | 164.02 | 139.29 | 128.38 | 240.61 | 280.8 | 115.45 |
Net Income Net Income Growth | 161.35 | 131.62 | 91.76 | 126.2 | 218.79 | 66.48 |
Earnings Per Share EPS Growth | 0.40 | 0.33 | 0.23 | 0.31 | 0.54 | 0.17 |
EPS Growth | 36.38% | 43.48% | -25.81% | -42.59% | 217.65% | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Real Estate Leasing and Management Industry Real Estate Leasing and Management Industry Growth | 30.02 | 32.58 | 34.09 | 41.88 | 45.68 |
Inter-Department Offsetting Inter-Department Offsetting Growth | -3.67 | - | - | - | - |
Pharmaceutical Manufacturing Industry Pharmaceutical Manufacturing Industry Growth | 866.9 | 914.52 | 1,089 | 1,087 | 819.01 |
Machinery manufacturing industry Machinery manufacturing industry Growth | 145.15 | 155.25 | 86.29 | 113.82 | 188.81 |
Total Total Growth | 1,038 | 1,102 | 1,209 | 1,243 | 1,054 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 480.97 | 408.14 | 446.44 | 689.79 | 504.12 | 289.27 |
Total Debt Total Debt Growth | 107.73 | 76 | 77.86 | 114.83 | 10.31 | 0.98 |
Net Cash (Debt) Net Cash Growth | 373.24 | 332.14 | 368.59 | 574.97 | 493.8 | 288.29 |
Net Cash Growth | 5.80% | -9.89% | -35.89% | 16.44% | 71.29% | -39.19% |
Net Cash Per Share Net Cash Per Share Growth | 0.94 | 0.83 | 0.92 | 1.41 | 1.22 | 0.74 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 167.64 | 207.89 | 158.15 | 151.14 | 323.04 | 136.4 |
Capital Expenditures CapEx Growth | -89.71 | -99.57 | -72.92 | -66.1 | -54.15 | -85.36 |
Free Cash Flow Free Cash Flow Growth | 77.93 | 108.32 | 85.23 | 85.04 | 268.89 | 51.03 |
Free Cash Flow Growth | -74.00% | 27.10% | 0.22% | -68.37% | 426.92% | -47.88% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 59.74% | 58.07% | 57.07% | 61.30% | 61.31% | 56.38% |
Operating Margin | 15.81% | 13.41% | 11.65% | 19.90% | 22.60% | 10.96% |
Pretax Margin | 18.16% | 14.71% | 11.13% | 14.64% | 23.38% | 8.88% |
Profit Margin | 15.55% | 12.68% | 8.32% | 10.44% | 17.61% | 6.31% |
FCF Margin | 7.51% | 10.43% | 7.73% | 7.03% | 21.64% | 4.84% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.082 | 0.082 | 0.069 | 0.110 |
Dividend Per Share Growth | 18.84% | 18.84% | -37.27% | - |
Dividend Yield | 0.62% | 0.80% | 0.85% | 1.03% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 30.69 | 31.38 | 36.12 | 35.21 | 24.99 | 65.63 |
P/FCF Ratio | 63.98 | 38.13 | 38.89 | 52.25 | 20.33 | 85.50 |
PS Ratio | 4.81 | 3.98 | 3.01 | 3.68 | 4.40 | 4.14 |